Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists

Journal of Rheumatology

Volumn 24, Issue 12, 1997, Pages 2283-2290

  Criswell, Lindsey A ^a,b,c   Such, Carol L ^a   Yelin, Edward H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Medicine ^*

^c Division of Rheumatology   (United States)

Author keywords

Antirheumatic drugs; Rheumatoid arthritis; Rheumatologists; Specialty

Indexed keywords

GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MULTIPLE REGRESSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOLOGY;

AGED; ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; GOLD; HUMANS; HYDROXYCHLOROQUINE; MALE; METHOTREXATE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PREDNISONE; RETROSPECTIVE STUDIES; RHEUMATOLOGY;

EID: 0031453915     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Cassel C, Rudberg M, Oshanksky S: The price of success: Health care in an aging society. Health Affairs 1992;11:87-99.
2. Rice D, LaPlante M: Medical expenditures for disability and disability comorbidity. Am J Public Health 1992;82:739-41.
3. Schlesinger M, Mechanic D: Challenges for managed competition from chronic illness. Health Affairs 1993;(suppl)12:123-37.
4. Manheim LM: Managed care and arthritis care: Patients and providers under the new medical care organizations. Arthritis Care Res 1995;8:298-303.
5. Schned E: Future care of rheumatoid arthritis in a managed care environment. Bull Rheum Dis 1993;42:1-3.
6. Yelin EH, Henke CJ, Kramer JS, Nevitt MC, Shearn MC, Epstein WV: A comparison of the treatment of rheumatoid arthritis in health maintenance organizations and fee-for-service practices. N Engl J Med 1985;312:962-7.
7. Nevitt MC, Yelin EH, Henke CJ, Epstein WV: Risk factors for hospitalization and surgery in patients with rheumatoid arthritis: Implications for capitated medical payment. Ann Intern Med 1986;105:421-8.
8. Yelin E, Henke C, Epstein W: The work dynamics of the person with rheumatoid arthritis. Arthritis Rheum 1987;30:507-12.
9. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
10. SAS, 6.08 ed. Cary, NC: SAS Institute, 1989.
11. Karim M, Zeger S: GEE: A SAS macro for longitudinal data analysis, 1st ed. Baltimore: Department of Biostatistics, The Johns Hopkins University, 1989.
12. Fleiss JL: Statistical Methods for Rates and Proportions, 2nd ed. New York: John Wiley, 1981:44-6.
13. Ward MM, Leigh JP, Fries JF: Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care. Arch Intern Med 1993;153:2229-37.
14. Yelin EH, Such CL, Criswell LA, Epstein WV: Outcomes for persons with rheumatoid arthritis with a rheumatologist and non-rheumatologist as the main physician for this condition. Med Care 1998;(in press).
15. Stross JK: Relationships between knowledge and experience in the use of disease-modifying antirheumatic drugs. A study of primary care practitioners. JAMA 1989;262:2721-3.